Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]

Hagop M. Kantarjian; Yasuhiro Oki; Jean Pierre Issa

doi:10.1182/blood-2006-08-041145

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]

Hagop M. Kantarjian, Yasuhiro Oki, Jean Pierre Issa

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	4291-4292
Number of pages	2
Journal	Blood
Volume	108
Issue number	13
DOIs	https://doi.org/10.1182/blood-2006-08-041145
State	Published - Dec 15 2006

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2006-08-041145

Cite this

@article{42b9ba36a56e4a4a9db5717e1487a06d,

title = "Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]",

author = "Kantarjian, {Hagop M.} and Yasuhiro Oki and Issa, {Jean Pierre}",

year = "2006",

month = dec,

day = "15",

doi = "10.1182/blood-2006-08-041145",

language = "English (US)",

volume = "108",

pages = "4291--4292",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "13",

}

TY - JOUR

T1 - Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]

AU - Kantarjian, Hagop M.

AU - Oki, Yasuhiro

AU - Issa, Jean Pierre

PY - 2006/12/15

Y1 - 2006/12/15

UR - http://www.scopus.com/inward/record.url?scp=33750531310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750531310&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-08-041145

DO - 10.1182/blood-2006-08-041145

M3 - Letter

C2 - 17148594

AN - SCOPUS:33750531310

SN - 0006-4971

VL - 108

SP - 4291

EP - 4292

JO - Blood

JF - Blood

IS - 13

ER -

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [2]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this